Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer

SIMPLE SUMMARY: Pathological complete response (pCR) after neoadjuvant chemotherapy can predict survival outcomes in patients with early triple negative breast cancer (TNBC). The immune microenvironment can affect response to chemotherapy. We combined several immune-related biomarkers (TILs, PD-L1 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerbelli, Bruna, Scagnoli, Simone, Mezi, Silvia, De Luca, Alessandro, Pisegna, Simona, Amabile, Maria Ida, Roberto, Michela, Fortunato, Lucio, Costarelli, Leopoldo, Pernazza, Angelina, Strigari, Lidia, Della Rocca, Carlo, Marchetti, Paolo, d’Amati, Giulia, Botticelli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565153/
https://www.ncbi.nlm.nih.gov/pubmed/32947953
http://dx.doi.org/10.3390/cancers12092648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565153/
https://www.ncbi.nlm.nih.gov/pubmed/32947953
http://dx.doi.org/10.3390/cancers12092648

Ejemplares similares